Roche has named the next CEO for its diagnostics efforts, as its prior division chief, Thomas Schinecker, is waiting in the wings to head up the Big Pharma overall starting next March.

On September 28, a series of activities for the 110th anniversary of Peking University's Medical Education, "the Collective Signing Ceremony of the University-Enterprise Joint Research & Development Platform", was held.

Taiwan-based diagnostic firm Micronbrane Medical announced on Wednesday that it raised $4.5 million in a Series A funding round.

Illumina Inc (ILMN.O), the top maker of DNA sequencers used to speed drug development and other research, on Thursday announced the launch of its next-generation NovaSeq X systems, which it said can generate more than 20,000 whole genomes per year, or 2.5 times that of prior sequencers.

On 29 September, Suzhou Novoprotein Scientific Co., Ltd. was listed on the STAR Market. The stock name is Novoprotein, the stock code is 688137. SH, with the issue price is 106.19 CNY / share, which broke after the opening, with a market capitalization of over CNY 5.6 billion.

OraSure Technologies announced on Wednesday that it has been awarded an $8.6 million contract from the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA).

Becton Dickinson and CerTest Biotec have made a PCR assay for monkeypox virus available commercially in the U.S. and other markets worldwide.

Recently, the TSure Nucleic Acid Analysis Device independently developed by Sansure obtained CE mark, which will further meet and expand the global testing market demands at all levels, and serve the construction of public health prevention and control system in every country better.s

Thermo Fisher Scientific said on Tuesday that its next-generation sequencing-based Oncomine Dx Target Test has been approved by the US FDA as a companion diagnostic (CDx) to identify patients with advanced RET-driven lung and thyroid cancers who may be eligible for Lilly¡¯s Retevmo (selpercatinib).

The US Food and Drug Administration said on Tuesday that it is updating its policy on Emergency Use Authorizations for COVID-19 tests and limiting its review of new submissions.

In order to align with Shanghai's goal of accelerating the construction of a scientific and technological innovation center, a high-level research institution dedicated to virology source innovation and clinical translation will be built in Shanghai.

The UK's National Institute for Health and Clinical Excellence has created a new program to evaluate innovative technologies and plans to assess Genedrive's MT-RNR1 test for antibiotics-induced hearing loss in infants via this new process, the company said on Monday.

BioIVT, a provider of research models and services for drug discovery and development, said on Monday that it has acquired Bulgarian biospecimen firm Fidelis Research.

Recently, Sansure Biotech, Hunan Dashengchong Medical Biotechnology, Santa Cruz Biotechnology, and Huanyu Shenghe Testing Technology jointly hosted the "Animal Health Industry Summit Forum", which was held in the Changsha Headquarters Industrial Park of Shengxiang Bio.

Digital pathology firms Paige and OptraScan announced on Thursday that they are partnering to streamline digital pathology workflows in the US, EU, and UK.

Virax Biolabs announced on Thursday that it has signed a deal with Cosmos Holdings to distribute Virax's monkeypox PCR tests in Europe.

Merck, a leading science and technology company, opened a viral clearance (VC) laboratory as part of the first building phase of its new € 29 million China Biologics Testing Center. The 5,000 square meter center is the first of its kind for Merck in China.

US Food and Drug Administration officials said Wednesday that over-the-counter molecular assays could bridge gaps in monkeypox testing, as agency officials also continued work on creating guidance specific to antigen tests for the disease.

PerkinElmer subsidiary Oxford Immunotec said Thursday it gained US Food and Drug Administration approval for its T-Cell Select reagent kit that automates sample preparation steps for its tuberculosis in vitro diagnostic assay.

On September 21, 2022, Lepu Medical was officially listed on the SIX Swiss Exchange. It is a critical milestone in the development of Lepu Medical and a brand new point for the company's comprehensive internationalization strategy.